S. Tochizawa

Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines.

N. Masumori, Y. Yabuuchi, Y. Ohmoto, 2008, Biomedical research.

Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity.

H. Hidaka, S. Tochizawa, T. Sudo, 2000, Biochemical pharmacology.

A flow cytometric method for determination of the interferon receptor IFNAR2 subunit in peripheral blood leukocyte subsets.

A. Tanigami, M. Muraguchi, Toyoki Mori, 2004, Journal of pharmacological and toxicological methods.

2(1H)-quinolinone derivatives as novel anti-arteriostenotic agents showing anti-thrombotic and anti-hyperplastic activities.

H. Hidaka, M. Okada, S. Tochizawa, 1998, Bioorganic & medicinal chemistry letters.

Functional expression of human type I interferon receptors in the mouse liver.

M. Muraguchi, Toyoki Mori, Y. Ohmoto, 2006, Biochemical and biophysical research communications.

Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double‐injury model

Y. Yoshida, S. Tochizawa, T. Sudo, 2000, British journal of pharmacology.